Navigation Links
OpGen recruits CEO to further gene-mapping business

Madison, Wis. The biotechnology firm OpGen hopes its new CEO will draw investment to its work in gene mapping, the company said on Monday. R.H. Joseph Shaw is the former CEO of medical firms Quantech and Cathra International.

I think Joe Shaw comes to OpGen with a good history of raising serious funds, and we hope he continues to do the same here, said Life Science Insights. OpGens technology may help identify the genes that result in the variability of patients response to therapy. This information may lead to better and......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 11/29/04


Related biology technology :

1. OpGen layoffs precede another funding round
2. OpGen forges agreement with Japanese importer
3. OpGen completes $5 million investment round
4. OpGen adds Thomas Pyle and James Ogle to board of directors
5. OpGen joins UW, Henry Ford Heath in Improving Brain Tumor Treatment
6. OpGen Creates Map of Worlds Most Lethal Fungus
7. OpGen Database Helps to Reduce Bioterrorist Threat
8. Better collaboration urged to further Wisconsin biotech
9. Johnson Controls jumping further into hybrid-vehicle battery world
10. While schools combat low tech enrollment, are businesses contributing to IT workforce woes?
11. CIOs focus on the business case while facing authority erosion
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... N.J. , Jan. 20, 2017 ... "Company"), a company that provides clinically useful molecular ... it has entered into a securities purchase agreement ... of 855,000 shares of common stock in a ... the Company has agreed to sell to the ...
(Date:1/21/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX ), ... and commercialization of innovative biopharmaceutical products for companion animals, ... North America 2016. ... the FDA approval of three innovative therapeutics in 2016, ... oral solution) and NOCITA ® (bupivacaine liposome injectable ...
(Date:1/20/2017)... , ... January 20, 2017 , ... The two newest ... treatment options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, ... lab space at 3624 Market Street. , Vironika is developing a treatment for ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology:
(Date:12/12/2016)... 2016  Researchers at Trinity College, Dublin, are ... combining the material with Silly Putty. The mixture (known ... able to sense pulse, blood pressure, respiration, and ... The research team,s findings were published ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/8/2016)... 8, 2016  Singulex, Inc., the leader in Next ... into a license and supply agreement with Thermo Fisher ... provides Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), ... is used to diagnose systemic bacterial infection and sepsis ... to aid in assessing the risk of critically ill ...
(Date:12/7/2016)... BioCatch , the global leader in behavioral biometrics, reported ... to over 40 granted and pending patents. ... , The Company,s IP portfolio ... System, Device, and Method Estimating Force Applied to a Touch Surface, ... hardware components needed to estimate the force and pressure applied to touch ...
Breaking Biology News(10 mins):